22
AVSF - Beacon Biosignals 2026, LLC updates its Form D — $894K sold
Fund raise update · Venture capital · Open-ended · Offering Indefinite · Sold $894K · BOSTON, MA · filed 2026-10-13
Alumni Ventures has closed a $541K venture capital fund focused on biosignals through its Beacon Biosignals 2026 LLC entity in Boston. The fund reached its target with 41 investors at a $5K minimum and is now fully deployed.
| Michael Collins | CEO of Alumni Ventures LLC, the Issuer's Sole Manager |
Signed by Hilary Ncala, Sr VP, Alumni Funds of Issuer's Sole Manager.
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.